BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 7587892)

  • 1. Treatment of human hepatocellular carcinoma by fibroblast-mediated human interferon alpha gene therapy in combination with adoptive chemoimmunotherapy.
    Cao X; Wang J; Zhang W; Chen G; Kong X; Tani K
    J Cancer Res Clin Oncol; 1995; 121(8):457-62. PubMed ID: 7642687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Growth inhibition of human hepatocellular carcinoma xenograft in nude mice by combined treatment with human cytokine-induced killer cells and chemotherapy].
    Shi M; Yao L; Wang FS; Lei ZY; Zhang B; Li WL; Liu JC; Tang ZR; Zhou GD
    Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):465-8. PubMed ID: 15555334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Enhanced immune functions and antitumor activity of fibroblast-mediated interleukin-2 gene therapy].
    Cao XT; Zhang WP; Tao Q
    Zhonghua Yi Xue Za Zhi; 1995 Sep; 75(9):521-4, 573. PubMed ID: 8556540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunological mechanism of human alpha-interferon gene therapy for treatment of melonoma].
    Chen M; Lin Z; Cao X
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2001 Sep; 17(5):306-8. PubMed ID: 11767713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effects on melanoma and immunological mechanism of human interferon-alpha gene therapy by fibroblasts].
    Chen M; Lin Z; Cao X
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2000 Sep; 16(5):298-301. PubMed ID: 11593666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental study on the treatment of human hepatocellular carcinoma by fibroblast-mediated human IFN-alpha gene therapy in combination with adoptive chemoimmunotherapy].
    Wang J; Cao X; Kong X
    Zhonghua Zhong Liu Za Zhi; 1995 Jul; 17(4):266-70. PubMed ID: 7587892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Locoregional immunochemotherapy in hepatocellular carcinoma.
    Kountouras J; Boura P; Kouklakis G
    Hepatogastroenterology; 2002; 49(46):1109-12. PubMed ID: 12143214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunology of hepatocellular carcinoma.
    Paroli M; Perrone A; Bonavita MS; Barnaba V
    Ital J Gastroenterol; 1991 Nov; 23(8):494-7. PubMed ID: 1661196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologic therapy of liver tumors.
    Prieto J; Qian C; Sangro B; Melero I; Mazzolini G
    Surg Clin North Am; 2004 Apr; 84(2):673-96. PubMed ID: 15062668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adoptive immunotherapy in postoperative hepatocellular carcinoma: a systemic review.
    Xie F; Zhang X; Li H; Zheng T; Xu F; Shen R; Yan L; Yang J; He J
    PLoS One; 2012; 7(8):e42879. PubMed ID: 22916174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Locoregional immuno-chemotherapy transplenic and transtumoral in vivo immunostimulation.
    Lygidakis NJ; Stringaris K
    Hepatogastroenterology; 1996; 43(8):440-7. PubMed ID: 8714242
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.